Holen Sie sich die Stockscreener-App
114.47
3.58%
3.96
Handel nachbörslich:
114.95
0.48
+0.42%
Schlusskurs vom Vortag:
$110.51
Offen:
$110.61
24-Stunden-Volumen:
727.89K
Relative Volume:
0.64
Marktkapitalisierung:
$12.37B
Einnahmen:
$769.10M
Nettoeinkommen (Verlust:
$46.67M
KGV:
327.06
EPS:
0.35
Netto-Cashflow:
$119.79M
1W Leistung:
+3.34%
1M Leistung:
+26.53%
6M Leistung:
+186.39%
1J Leistung:
+58.99%
1-Tages-Spanne:
$110.08
$114.90
1-Wochen-Bereich:
$110.05
$114.90
52-Wochen-Spanne:
$28.66
$122.21
Corcept Therapeutics Inc Stock (CORT) Company Profile
Firmenname
Corcept Therapeutics Inc
Sektor
Branche
Telefon
650.688.8803
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
114.47 | 12.13B | 769.10M | 46.67M | 119.79M | 0.35 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-05-13 | Hochstufung | UBS | Neutral → Buy |
| 2026-03-26 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-12-31 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | Eingeleitet | UBS | Neutral |
| 2025-11-18 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-06 | Hochstufung | Truist | Hold → Buy |
| 2023-04-11 | Eingeleitet | SVB Securities | Market Perform |
| 2023-04-04 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-01 | Herabstufung | Truist | Buy → Hold |
| 2022-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-27 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-24 | Eingeleitet | Jefferies | Buy |
| 2019-09-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-04 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Bestätigt | Stifel | Hold |
| 2018-05-31 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-09 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Eingeleitet | Stifel | Buy |
| 2017-02-02 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-04-21 | Eingeleitet | FBR Capital | Outperform |
| 2014-01-13 | Herabstufung | Stifel | Buy → Hold |
| 2013-08-09 | Herabstufung | Janney | Buy → Neutral |
| 2013-08-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-01-06 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Hochstufung | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Alle ansehen
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
23,257 Shares in Corcept Therapeutics Incorporated $CORT Purchased by GSA Capital Partners LLP - marketbeat.com
Corcept therapeutics chief development officer sells $1.8m in stock - Investing.com
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Corcept Therapeutics (CORT) CBO reports 17,530-share stock gifts and trust holdings - Stock Titan
Renaissance Technologies (CORT) discloses 4.90% beneficial stake in Corcept Therapeutics - Stock Titan
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Sean Maduck Sells 1,031 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - marketbeat.com
William Guyer Sells 16,300 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - marketbeat.com
Corcept chief development officer sells $418,561 of stock By Investing.com - Investing.com Nigeria
Corcept chief development officer sells $418,561 of stock - Investing.com
Sei Investments Co. Sells 62,377 Shares of Corcept Therapeutics Incorporated $CORT - marketbeat.com
Amundi Acquires New Shares in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline (PR Newswire) - Aktiellt
California State Teachers Retirement System Boosts Stake in Corcept Therapeutics Incorporated $CORT - marketbeat.com
12,478 Shares in Corcept Therapeutics Incorporated $CORT Purchased by Evanson Financial LLC - marketbeat.com
Corcept Therapeutics Incorporat (CORT) Stock forecasts - Yahoo Finance UK
Corcept Therapeutics (CORT) Stock May Trade At A Discount Yet A Premium On Sales - Yahoo Finance
Corcept CDO William Guyer sells $418,561 in common stock By Investing.com - Investing.com South Africa
Corcept CDO William Guyer sells $418,561 in common stock - Investing.com
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 3,700 Shares - MarketBeat
Janus Henderson Group PLC Acquires 10,817 Shares of Corcept Therapeutics Incorporated $CORT - marketbeat.com
Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,305 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Joseph Douglas Lyon Sells 1,540 Shares of Stock - MarketBeat
Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation - Yahoo Finance
Corcept Therapeutics' (NASDAQ:CORT) Anemic Earnings Might Be Worse Than You Think - Moomoo
Parallel Advisors LLC Buys 96,763 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
CORT (NASDAQ: CORT) insider schedules 20,000-share option-related sale - Stock Titan
John Hussman's Top Q2 2026 Move: Exiting Corcept Therapeutics In - GuruFocus
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) CFO Sells $9,176,800.00 in Stock - MarketBeat
Corcept Therapeutics (CORT) CFO exercises options and sells 80,000 shares - Stock Titan
CORCEPT THERAPEUTICS INC SEC Filing (Aug 3, 2026) - Stock Titan
FAS Wealth Partners Inc. Grows Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Perceptive Advisors LLC Takes Position in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Edgestream Partners L.P. Invests $2.79 Million in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Corcept Therapeutics (NASDAQ:CORT) Upgraded at Wall Street Zen - marketbeat.com
Corcept: Commercial Evidence with Agentic Call Report - Veeva
Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know - webull.com
Piper Sandler Reaffirms Their Buy Rating on Corcept Therapeutics (CORT) - The Globe and Mail
27,200 Shares in Corcept Therapeutics Incorporated $CORT Purchased by OMERS ADMINISTRATION Corp - marketbeat.com
Form 144 | Corcept Therapeutics(CORT.US) Officer Proposes to Sell 4.59 Million in Common Stocks - Moomoo
Corcept Therapeutics Raises 2026 Revenue Outlook on Momentum - The Globe and Mail
Corcept Therapeutics (NASDAQ:CORT) Reaches New 52-Week High Following Earnings Beat - marketbeat.com
Corcept Therapeutics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Corcept: Q2 Earnings Snapshot - KVUE
Corcept Therapeutics (CORT) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update - Business Wire
Bank of New York Mellon Corp Has $21.92 Million Stock Position in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Spotting Winners: Corcept (NASDAQ:CORT) And Branded Pharmaceuticals Stocks In Q1 - Yahoo Finance
Corcept (CORT) Q2 Earnings: What To Expect - TradingView
CORT|Corcept Therapeutics Inc|Price:91.090|Chg%:-4.270 - TradingKey
Corcept Therapeutics Inc (CORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):